Back to search results

Gait Metrics in Stroke, TBI, and MS with Functional Electrical Stimulation

This study is looking at how a device called Functional Electrical Stimulation (FES) affects walking in people with stroke, traumatic brain injury (TBI), or multiple sclerosis (MS). FES uses gentle electrical currents to help activate muscles and improve movement. The study will compare walking speed, step length, and how evenly you walk when using FES (specifically the L300 device) versus your usual care without the device. Researchers want to see if FES helps improve walking and if people with different conditions respond differently. You may be able to join if you are 18-80 years old, have one of these conditions, experience foot drop, and can walk at least 10 meters.

Study design
This is an interventional study planning to enroll 90 participants. It compares Functional Electrical Stimulation (FES) to normal care.
What's involved
The study measures changes in gait speed from enrollment to the end of treatment at 12 weeks.
Compensation
Not stated in the trial record.
Follow-up
Participants are followed for 12 weeks after enrollment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07492602

Comparison of Gait Metrics in Patients With Stroke, Traumatic Brain Injury, and Multiple Sclerosis

Not Yet Recruiting
NAAges 18–80InterventionalTreatment
Casa Colina Hospital and Centers for Healthcare
~90 participants
Updated 2026-03-27 on ClinicalTrials.gov
What's tested:Functional Electrical StimulationNormal care

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Changes in gait speed
Measured over From enrollment to the end of treatment at 12 weeks

Conditions

Stroke
Traumatic Brain Injury
Multiple Sclerosis

Explore related trials

Multiple SclerosisStrokeTraumatic Encephalopathy

NCT07492602

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Casa Colina Hospital and Centers for Healthcare

    Pomona, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Emily Rosario, PhD
[email protected]
909-596-7733 · ext. 3036
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults aged 18-80 years.
Diagnosis of stroke, traumatic brain injury, or multiple sclerosis confirmed by medical records.
Presence of foot drop or impaired ankle dorsiflexion during gait.
Ability to ambulate at least 10 meters with or without assistive devices.
Cognitive ability to follow simple instructions and provide informed consent.

Exclusion

Severe lower limb contractures or orthopedic conditions that limit gait.
Implanted electrical devices (e.g., pacemaker) contraindicating FES use.
Uncontrolled medical conditions (e.g., severe cardiac disease).
Pregnancy.
Skin integrity issues preventing electrode placement.
Participation in other interventional gait studies within the past 3 months.

What this trial measures

  • Changes in gait speedFrom enrollment to the end of treatment at 12 weeks

    Measuring changes in gait speed